• Home
  • Industry News
  • AstraZeneca takes latest scientific advances in oncology to major US And European congresses

AstraZeneca takes latest scientific advances in oncology to major US And European congresses


AstraZenecaAstraZeneca and its global biologics research and development arm, MedImmune, will continue the oncology momentum built during 2016 with a strong end-of-year presence at three major congresses. In total, 50 abstracts - including 15 oral presentations - have been accepted across:

Source link